You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epclusa

Showing 1 - 25 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Elimination of Hepatitis C Virus Among Users of Substances

Not yet recruiting
  • Hepatitis C in Substance Users
  • Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
  • (no location specified)
Aug 14, 2022

Liver Transplant, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)

Active, not recruiting
  • Liver Transplant
  • Hepatitis C
  • Pittsburgh, Pennsylvania
    UPMC
Oct 6, 2022

Hepatitis C, Awaiting Organ Transplant Trial in Boston (Sofosbuvir/velpatasvir, Monitoring)

Recruiting
  • Hepatitis C
  • Awaiting Organ Transplant
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 14, 2022

Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Epclusa
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Eliminating HCV Infection Among PWUD

Recruiting
  • Hepatitis C, Chronic
  • Drug Use
  • Epclusa
  • Vancouver, British Columbia, Canada
    Vancouver Infectious Diseases Centre
Jul 22, 2022

Kidney Transplantation, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)

Active, not recruiting
  • Kidney Transplantation
  • Hepatitis C
  • Pittsburgh, Pennsylvania
    UPMC
Oct 27, 2021

Heart Failure Trial in Los Angeles, Durham, Dallas (Epclusa)

Recruiting
  • Heart Failure
  • Epclusa
  • Los Angeles, California
  • +2 more
Jan 27, 2022

Hepatitis C, Opioid-Related Disorders, Injection Drug Use Trial in Hazard (Sofosbuvir/velpatasvir (Epclusa®))

Recruiting
  • Hepatitis C
  • +2 more
  • Sofosbuvir/velpatasvir (Epclusa®)
  • Hazard, Kentucky
    ARH Medical Mall
Sep 25, 2022

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)

Recruiting
  • Hepatitis C, Chronic
  • Pregnancy; Infection
  • Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
  • Denver, Colorado
  • +4 more
Dec 3, 2022

Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)

Completed
  • Hepatitis C, Chronic
  • Opioid-use Disorder
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital of UPMC
Aug 19, 2022

Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)

Recruiting
  • Hepatitis C
  • HCV RNA Point of Care
  • +2 more
  • Sydney, New South Wales, Australia
    NUAA NSP
Aug 19, 2022

Kidney Transplant, Hepatitis C, HCV Trial in Columbus (Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Glecaprevir/Pibrentasvir

Completed
  • Kidney Transplant
  • +2 more
  • Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
  • Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET]
  • Columbus, Ohio
    Brenda Cuson
Jul 29, 2021

SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

Recruiting
  • Hepatitis C
  • Epclusa (sofosbuvir and velpatasvir)
  • Guangzhou, Guangdong, China
    Deparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021

Hepatitis C, Lung Transplant Trial in Pittsburgh (Epclusa)

Active, not recruiting
  • Hepatitis C
  • Lung Transplant
  • Epclusa
  • Pittsburgh, Pennsylvania
    UPMC
Oct 4, 2021

End Stage Renal Disease Trial in United States (Epclusa)

Recruiting
  • End Stage Renal Disease
  • Epclusa
  • Birmingham, Alabama
  • +8 more
Feb 1, 2023

Strategies for Hepatitis C Testing and Treatment in Aboriginal

Recruiting
  • Hepatitis C
  • +5 more
  • Fingerstick GeneXpert HCV RNA quantitative assay
  • +2 more
  • Lismore, New South Wales, Australia
  • +3 more
Apr 13, 2022

Hepatitis C, Chronic Trial in Pittsburgh (Sofosbuvir-Velpatasvir Drug Combination)

Recruiting
  • Hepatitis C, Chronic
  • Sofosbuvir-Velpatasvir Drug Combination
  • Pittsburgh, Pennsylvania
    University of Pittsburgh, Magee Womens Hospital
Sep 3, 2021

Chronic Hepatitis C Trial in Porto Alegre (Telemedicine, Velpatasvir/Sofosbuvir)

Active, not recruiting
  • Chronic Hepatitis C
  • Porto Alegre, Rio Grande Do Sul, Brazil
    Hospital de Clínicas de Porto Alegre
Aug 24, 2021

Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)

Completed
Has Results
  • Chronic Hepatitis C
  • Baltimore, Maryland
    Institute of Human Virology University of Maryland
Apr 26, 2021

Hepatitis C, Cryoglobulinemia Trial in New York (Harvoni, Epclusa)

Completed
Has Results
  • Hepatitis C
  • Cryoglobulinemia
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 23, 2020

Hepatitis C Trial in Kaohsiung (Epclusa)

Active, not recruiting
  • Hepatitis C
  • Epclusa
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Hospital
Jul 8, 2020

HCV Infection Trial in Christchurch (SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol)

Completed
Has Results
  • HCV Infection
  • Christchurch, New Zealand
    (unnamed)
Aug 17, 2020

Kidney Transplant, Hepatitis C Trial in Richmond (Direct acting Anti-Viral Therapy using Epclusa or Zepatier)

Completed
  • Kidney Transplant
  • Hepatitis C
  • Direct acting Anti-Viral Therapy using Epclusa or Zepatier
  • Richmond, Virginia
    Virginia Commonwealth University
Mar 26, 2020

Hepatitis C, Acute Hepatitis C Trial in Germany (Sofosbuvir and Velpatasvir)

Completed
  • Hepatitis C
  • Acute Hepatitis C
  • Sofosbuvir and Velpatasvir
  • Berlin-Friedrichshain, Germany
  • +13 more
Jul 2, 2021